RE: Rns17 Aug 2022 10:38
Dilly seems a personable and polite person, with scientific credibility. But this past year has demonstrated incredible commercial naivete in the way the Theorem Rx deal was structured in such an open ended way (for which the board bears collective responsibility) and the resulting damage to the SP. This led to the company communications masterstroke of announcing the placing at 10p just before the AGM which set the bar quite low PR- wise. The drunk lady at the AGM was an interesting watch, and Dilly handled her without having a meltdown.
That being said, l am positive on this RNS as it shows Dilly recognises the need for more professional communications, and she gains external perspective and expertise from Adam Hargreaves being more involved (but not on board, geddit? :-). The pros and cons of his involvement have been previously debated but l wish him the best in walking the regulatory tightrope, and l am thankful for his sensible posts with his wider industry perspective.
I took a quick look at https://www.vformation.biz/
Seems a rather oestrogen heavy outfit, maybe Dilly went to Brownies with the directors. In any case, am prepared to see how they perform.
We still need actual commercial news to shift the SP off it's arse, where it is currently sat comfortably :-(
Optimistically yours,
Z